Now a new study compares a standardized decaffeinated green tea extract capsule with placebo.
Researchers in Florida examined 111 healthy adults, age 21-70, over 3 months for blood pressure, blood cholesterol, serum oxidative stress, and inflammatory markers.
The volunteers took two decaf green tea extract capsules twice a day or placebo twice a day in the double-blind study.
Within the first 3 weeks, the green tea participants showed lower blood pressure in both systolic and diastolic measurements.
Decaf green tea lowers blood pressure
By three months, this caffeine blood pressure study showed that systolic blood pressure remained significantly lower for the green tea group.
Also total cholesterol was lower, oxidative stress was lower, and the inflammatory blood marker was lower for the green tea group after 3 months.
In general, most studies have shown that caffeine enhances green tea benefits.
But this study supports potential cardiovascular risk reduction even with decaf green tea for those who might be sensitive to caffeine (Nantz MP, Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study, Nutrition, October 2008).
That's great news for people who choose decaf green tea.
Learn more about caffeine and your health with a free subscription to the Green Tea Health Newsletter:
This page last updated by Sharon Jones.
Published and Available on Amazon NOW!
With over 250 pages and 540 referenced scientific studies, this book includes chapters on
Growing lemon balm, Alzheimer's
Anti-bacterial, anti-fungal, anti-microbial, and anti-viral activities
Anti-inflammatory and antioxidant properties, Anxiety
Belly fat, Cancer, Cosmetics, Depression, Diabetes, Heart disease
Herpes and cold sores, Hyperactivity, Indigestion, Insomnia
Irritable bowel syndrome, Memory improvement, Obesity
Premenstrual syndrome, Spinal cord injury, Stress, Thyroid , Ulcers
Order by title from Amazon now, or click the link provided above
Subscribe now and don't miss a single issue.
Find out more!